Nephrology Medicines – Kidney &
Renal Disorder Treatments

Kidney diseases often progress quietly, and some of the newest treatments are approved abroad long before they reach Indian pharmacies. This page lists the nephrology medicines we can help patients in India access through the Named Patient Program, with a valid prescription from their nephrologist.

Anrikefon

Evrenzo

Filspari

Korsuva

Oxlumo

Pegmolesatide

Kidney conditions covered on this page

Primary IgA nephropathy (IgAN) in adults at risk of rapid disease progression
Moderate to severe itching (pruritus) in adults with chronic kidney disease who are on hemodialysis

Nephrology medicines available through NPP

Filspari (sparsentan)

A dual endothelin and angiotensin II receptor antagonist for adults with primary IgA nephropathy at risk of rapid progression. It is approved under accelerated approval based on reduction of proteinuria and needs enrolment in the Filspari REMS programme before starting. Read more about Filspari in India.

Korsuva (difelikefalin)

A kappa opioid receptor agonist for moderate to severe itching in adults with chronic kidney disease on hemodialysis. It is given by a healthcare provider into the dialysis line at the end of each session. See Korsuva availability in India.

How to access a kidney medicine that is not available in India

Your nephrologist writes a prescription naming the medicine, dose and duration.
You or your doctor send the prescription and patient details to our team.
We arrange the import with full CDSCO documentation (Form 12A & 12B, Bill of Entry, invoice and packing list).
Temperature-sensitive medicines travel in a controlled cold chain and are delivered to the patient or hospital.

Not sure if your medicine qualifies? Send us an enquiry.

Frequently Asked
Questions

Here are answers to questions
we're often asked.

Find your Answers?

For Healthcare Professionals

Nephrology

Nephrology Medicines – Kidney & Renal Disorder Treatments